Anti-Hu associated encephalitis: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 62: Line 62:
[[Category:Autoimmune diseases]]
[[Category:Autoimmune diseases]]
[[Category:Paraneoplastic syndromes]]
[[Category:Paraneoplastic syndromes]]
== Anti-Hu associated encephalitis ==
<gallery>
File:The_Limbic_System_and_Nearby_Structures_-_John_Taylor.jpg|The limbic system and nearby structures
File:Small_cell_carcinoma_(3923396504).jpg|Small cell carcinoma
</gallery>

Latest revision as of 02:06, 18 February 2025

Anti-Hu associated encephalitis
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Memory loss, seizures, confusion, personality changes
Complications
Onset
Duration
Types
Causes Autoimmune response
Risks
Diagnosis Clinical evaluation, detection of anti-Hu antibodies
Differential diagnosis N/A
Prevention N/A
Treatment Immunotherapy, corticosteroids, plasmapheresis
Medication N/A
Prognosis Variable
Frequency Rare
Deaths N/A


Anti-Hu associated encephalitis is a rare neurological disorder characterized by inflammation of the brain due to an autoimmune response. This condition is associated with the presence of anti-Hu antibodies, which are directed against neuronal antigens. It is often linked to paraneoplastic syndromes, particularly in patients with small cell lung cancer.

Pathophysiology

Anti-Hu associated encephalitis is an autoimmune disorder where the body's immune system mistakenly attacks its own neurons. The presence of anti-Hu antibodies is indicative of an immune response against neuronal proteins. These antibodies are often produced in response to cancer, most commonly small cell lung cancer, but can also be associated with other malignancies such as neuroblastoma.

Clinical Presentation

Patients with anti-Hu associated encephalitis typically present with a variety of neurological symptoms. These may include:

The onset of symptoms can be subacute, and they may progress rapidly if not treated.

Diagnosis

Diagnosis of anti-Hu associated encephalitis involves a combination of clinical evaluation and laboratory testing. Key diagnostic steps include:

  • Detection of anti-Hu antibodies in the serum or cerebrospinal fluid (CSF)
  • Magnetic resonance imaging (MRI) of the brain to identify areas of inflammation
  • Electroencephalogram (EEG) to assess electrical activity in the brain
  • Lumbar puncture to analyze CSF for inflammatory markers

Treatment

The primary goal of treatment is to suppress the autoimmune response and manage symptoms. Treatment options include:

  • Immunotherapy with agents such as intravenous immunoglobulin (IVIG) or rituximab
  • Corticosteroids to reduce inflammation
  • Plasmapheresis to remove antibodies from the blood
  • Treatment of the underlying cancer, if present, to reduce antibody production

Prognosis

The prognosis for patients with anti-Hu associated encephalitis varies. Early diagnosis and treatment can improve outcomes, but some patients may experience persistent neurological deficits. The presence of an underlying malignancy can also affect the overall prognosis.

Also see


edit 

WikiMD neurology

Anti-Hu associated encephalitis